Skip to content

The Effectiveness of Video-capsule Endoscopy in Gastrointestinal Bleeding of Obscure Origin

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01424254
Enrollment
79
Registered
2011-08-26
Start date
2003-10-31
Completion date
2011-03-31
Last updated
2011-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Bleeding

Keywords

Gastrointestinal Bleeding of Obscure Origin

Brief summary

The study objective is to compare the cost-effectiveness of VCE to push enteroscopy in patients with gastrointestinal bleeding of obscure origin with a negative initial work-up.

Detailed description

Background: The introduction of the wireless capsule endoscopy (WCE) may dramatically alter the management of patients with small bowel disease such as chronic gastrointestinal bleeding of obscure origin (CGB). Yet, to date, this non invasive technique has undergone widespread diffusion in the absence of properly designed prospective comparative cost-effectiveness evaluations. Objectives: To examine the clinical impact and cost-effectiveness of a novel approach employing WCE compared to that of push enteroscopy (PE). Hypothesis: WCE is more cost-effective than PE in patients with CGB. Study design: We propose a randomized clinical trial comparing WCE to PE. Study population: Patients with CGB having undergone initial normal assessment with gastroscopy, colonoscopy and radiological examination of the small bowel. Outcomes: Primary objective: To compare the detection rates of clinically significant small bowel lesions using WCE versus PE in CGB patients randomized to either modality. Secondary objectives: To determine the cure rate for each technique after 6 months, the cost-effectiveness of WCE versus PE, the type of small bowel lesions most likely to impact on clinical care, inter-rater variability in reading WCE examinations, the feasibility of WCE interpretation by a dedicated technician, the safety of each imaging modality, and to compare patient satisfaction and quality of life between the two groups.

Interventions

DEVICECapsule GIVEN IMAGING

Injection of Capsule Endoscopy

PROCEDUREPush-Enteroscopy

currently recommended standard

Sponsors

American Society for Gastrointestinal Endoscopy
CollaboratorOTHER
American College of Gastroenterology
CollaboratorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years old * Normal gastroscopy, colonoscopy and small bowel follow through in the last 3 months

Exclusion criteria

* Demonstrable source of blood outside the GI tract * Significant cardiopulmonary disease * Suspicion of strictures or fistulae of the GI tract * Pregnancy * Numerous small intestinal diverticula * Zenker's diverticulum * Extensive Crohn's enteritis

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the detection rate of clinically significant lesions thought to be responsible for the patients with gastrointestinal bleeding of obscure origin12 months

Secondary

MeasureTime frameDescription
blood transfusion requirements12 months
Number of required imaging tests (i.e: gastroscopy, colonoscopy, etc)12 months
resolution of the anemia/recurrent bleeding12 months
days away from usual activities (protocol unrelated)12 months
patient satisfactionFollowing procedure at randomizationPatient satisfaction questionnaire
hospitalization/length of stay12 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026